TY - JOUR
T1 - Visceral chemical nociception in mice lacking μ-opioid receptors
T2 - Effects of morphine, SNC80 and U-50,488
AU - Sora, Ichiro
AU - Li, Xiao Fei
AU - Funada, Masahiko
AU - Kinsey, Stephen
AU - R. Uhl, George
PY - 1999/2/5
Y1 - 1999/2/5
N2 - Writhing responses to intraperitoneal acetic acid administration and their modulation by μ-, κ- and δ-opioid receptor agonists were compared in wild-type and μ-opioid receptor knockout mice. Unpretreated homozygous knockout mice displayed less writhing than wild-type mice. U-50,488 [trans-3,4-dichloro-N-methyl-N-[2-(1-pyrolidinyl)cyclohexyl]-benzeneacetamide]) reduced writhing responses in wild-type and knockouts. Morphine and SNC80 [(+)-4-[9-α-R)-α-(2S,5RO-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide] were effective in wild-type mice but ineffective in knockouts. μ-opioid receptors appear to play important roles in responses to this visceral nociceptive stimulus and its modulation by μ- and δ-opioid receptor agonists. Copyright (C) 1999 Elsevier Science B.V.
AB - Writhing responses to intraperitoneal acetic acid administration and their modulation by μ-, κ- and δ-opioid receptor agonists were compared in wild-type and μ-opioid receptor knockout mice. Unpretreated homozygous knockout mice displayed less writhing than wild-type mice. U-50,488 [trans-3,4-dichloro-N-methyl-N-[2-(1-pyrolidinyl)cyclohexyl]-benzeneacetamide]) reduced writhing responses in wild-type and knockouts. Morphine and SNC80 [(+)-4-[9-α-R)-α-(2S,5RO-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide] were effective in wild-type mice but ineffective in knockouts. μ-opioid receptors appear to play important roles in responses to this visceral nociceptive stimulus and its modulation by μ- and δ-opioid receptor agonists. Copyright (C) 1999 Elsevier Science B.V.
KW - μ-Opioid receptor knockout mouse
KW - Visceral pain
KW - Writhing test
UR - http://www.scopus.com/inward/record.url?scp=0032993957&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032993957&partnerID=8YFLogxK
U2 - 10.1016/S0014-2999(98)00933-9
DO - 10.1016/S0014-2999(98)00933-9
M3 - Article
C2 - 10082217
AN - SCOPUS:0032993957
SN - 0014-2999
VL - 366
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
IS - 2-3
ER -